PPARγ and apoptosis in cancer

PPAR Research

Volumn , Issue , 2008, Pages

  Elrod, Heath A ^a   Sun, Shi Yong ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

15 DEOXY DELTA 12,14 PROSTAGLANDIN J2; 2 CHLORO 5 NITRO N (4 PYRIDYL)BENZAMIDE; 2 CHLORO 5 NITROBENZANILIDE; 2 CYANO 3,12 DIOXOOLEANA 1,9 DIEN 28 OIC ACID; 2,4 THIAZOLIDINEDIONE DERIVATIVE; 3 [3 TERT BUTYLTHIO 1 (4 CHLOROBENZYL) 5 ISOPROPYL 2 INDOLYL] 2,2 DIMETHYLPROPIONIC ACID; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 6 [1 (5,6,7,8 TETRAHYDRO 3,5,5,8,8 PENTAMETHYL 2 NAPHTHYL)CYCLOPROPYL]NICOTINIC ACID; AGN 194204; ANTINEOPLASTIC AGENT; CARBOPLATIN; CELECOXIB; CH 11; CIGLITAZONE; DOCETAXEL; ETOPOSIDE; IMATINIB; ISOTRETINOIN; N (2 BENZOYLPHENYL) O [2 (METHYL 2 PYRIDINYLAMINO)ETHYL]TYROSINE; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; NETOGLITAZONE; PACLITAXEL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; PIOGLITAZONE; PROSTAGLANDIN; RETINOIC ACID; ROSIGLITAZONE; RS 5444; TROGLITAZONE; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; TZD 18; UNINDEXED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; BLADDER CANCER; BRAIN CANCER; BREAST CANCER; CANCER CELL; CANCER THERAPY; CELL DIFFERENTIATION; CELL GROWTH; CELL TYPE; CHEMOPROPHYLAXIS; COLON CANCER; DRUG MECHANISM; ESOPHAGUS CANCER; HUMAN; LIPID METABOLISM; LIVER CELL CARCINOMA; LUNG CANCER; LYMPHOMA; MULTIPLE MYELOMA; NEOPLASM; NONHUMAN; PANCREAS CANCER; PROTEIN FUNCTION; REVIEW; STOMACH CANCER;

EID: 47349086201     PISSN: 16874757     EISSN: 16874765     Source Type: Journal    
DOI: 10.1155/2008/704165     Document Type: Review

References (82)

1. Han S., Roman J., Peroxisome proliferator-activated receptor γ: a novel target for cancer therapeutics? Anti-Cancer Drugs 2007 18 3 237 244
2. Sertznig P., Seifert M., Tilgen W., Reichrath J., Present concepts and future outlook: function of peroxisome proliferator-activated receptors (PPARs) for pathogenesis, progression, and therapy of cancer Journal of Cellular Physiology 2007 212 1 1 12
3. Lehrke M., Lazar M. A., The many faces of PPAR γ Cell 2005 123 6 993 999
4. Palmer C. N. A., Hsu M.-H., Griffin K. J., Johnson E. F., Novel sequence determinants in peroxisome proliferator signaling Journal of Biological Chemistry 1995 270 27 16114 16121
5. Yu S., Reddy J. K., Transcription coactivators for peroxisome proliferator-activated receptors Biochimica et Biophysica Acta 2007 1771 8 936 951
6. Forman B. M., Tontonoz P., Chen J., Brun R. P., Spiegelman B. M., Evans R. M., 15-deoxy- Δ 12, 14 -prostaglandin J 2 is a ligand for the adipocyte determination factor PPAR γ Cell 1995 83 5 803 812
7. Kliewer S. A., Lenhard J. M., Willson T. M., Patel I., Morris D. C., Lehmann J. M., A prostaglandin J 2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation Cell 1995 83 5 813 819
8. Clay C. E., Monjazeb A., Thorburn J., Chilton F. H., High K. P., 15-deoxy- Δ 12, 14 -prostaglandin J 2 -induced apoptosis does not require PPAR γ in breast cancer cells Journal of Lipid Research 2002 43 11 1818 1828
9. Ohta K., Endo T., Haraguchi K., Hershman J. M., Onaya T., Ligands for peroxisome proliferator-activated receptor γ inhibit growth and induce apoptosis of human papillary thyroid carcinoma cells Journal of Clinical Endocrinology and Metabolism 2001 86 5 2170 2177
10. Martelli M. L., Iuliano R., Le Pera I., Inhibitory effects of peroxisome proliferator-activated receptor γ on thyroid carcinoma cell growth Journal of Clinical Endocrinology and Metabolism 2002 87 10 4728 4735
11. Kato Y., Ying H., Zhao L., PPAR γ insufficiency promotes follicular thyroid carcinogenesis via activation of the nuclear factor- κ B signaling pathway Oncogene 2006 25 19 2736 2747
12. Shimada T., Kojima K., Yoshiura K., Hiraishi H., Terano A., Characteristics of the peroxisome proliferator activated receptor γ (PPAR γ) ligand induced apoptosis in colon cancer cells Gut 2002 50 5 658 664
13. Satoh T., Toyoda M., Hoshino H., Activation of peroxisome proliferator-activated receptor- γ stimulates the growth arrest and DNA-damage inducible 153 gene in non-small cell lung carcinoma cells Oncogene 2002 21 14 2171 2180
14. Baek S. J., Wilson L. C., Hsi L. C., Eling T. E., Troglitazone, a peroxisome proliferator-activated receptor γ (PPAR γ) ligand, selectively induces the early growth response-1 gene independently of PPAR γ: a novel mechanism for its anti-tumorigenic activity Journal of Biological Chemistry 2003 278 8 5845 5853
15. Baek S. J., Kim J.-S., Nixon J. B., DiAugustine R. P., Eling T. E., Expression of NAG-1, a transforming growth factor- β superfamily member, by troglitazone requires the early growth response gene EGR-1 Journal of Biological Chemistry 2004 279 8 6883 6892
16. Li M., Lee T. W., Yim A. P. C., Mok T. S. K., Chen G. G., Apoptosis induced by troglitazone is both peroxisome proliterator-activated receptor- γ-and ERK-dependent in human non-small lung cancer cells Journal of Cellular Physiology 2006 209 2 428 438
17. Pandhare J., Cooper S. K., Phang J. M., Proline oxidase, a proapoptotic gene, is induced by troglitazone: evidence for both peroxisome proliferator-activated receptor γ -dependent and -independent mechanisms Journal of Biological Chemistry 2006 281 4 2044 2052
18. Shiau C.-W., Yang C.-C., Kulp S. K., Thiazolidenediones mediate apoptosis in prostate cancer cells in part through inhibition of Bcl-xL/Bcl-2 functions independently of PPAR γ Cancer Research 2005 65 4 1561 1569
19. Nikitakis N. G., Siavash H., Hebert C., Reynolds M. A., Hamburger A. W., Sauk J. J., 15-PG J 2, but not thiazolidinediones, inhibits cell growth, induces apoptosis, and causes downregulation of Stat3 in human oral SCCa cells British Journal of Cancer 2002 87 12 1396 1403
20. Chaffer C. L., Thomas D. M., Thompson E. W., Williams E. D., PPAR γ -independent induction of growth arrest and apoptosis in prostate and bladder carcinoma BMC Cancer 2006 6, article 53 1 13
21. Piva R., Gianferretti P., Ciucci A., Taulli R., Belardo G., Santoro M. G., 15-deoxy- Δ 12, 14 -prostaglandin J 2 induces apoptosis in human malignant B cells: an effect associated with inhibition of NF- κ B activity and down-regulation of antiapoptotic proteins Blood 2005 105 4 1750 1758
22. Bonofiglio D., Aquila S., Catalano S., Peroxisome proliferator-activated receptor- γ activates p53 gene promoter binding to the nuclear factor- κ B sequence in human MCF7 breast cancer cells Molecular Endocrinology 2006 20 12 3083 3092
23. Steller H., Mechanisms and genes of cellular suicide Science 1995 267 5203 1445 1449
24. Hengartner M. O., The biochemistry of apoptosis Nature 2000 407 6805 770 776
25. Debatin K.-M., Krammer P. H., Death receptors in chemotherapy and cancer Oncogene 2004 23 16 2950 2966
26. Shroff E. H., Snyder C., Chandel N. S., Role of Bcl-2 family members in anoxia induced cell death Cell Cycle 2007 6 7 807 809
27. Ashkenazi A., Dixit V. M., Death receptors: signaling and modulation Science 1998 281 5381 1305 1308
28. Elrod H. A., Sun S.-Y., Modulation of death receptors by cancer therapeutic agents Cancer Biology and Therapy 2007 7 2 163 173
29. Guan Y.-F., Zhang Y.-H., Breyer R. M., Davis L., Breyer M. D., Expression of peroxisome proliferator-activated receptor γ (PPAR γ) in human transitional bladder cancer and its role in inducing cell death Neoplasia 1999 1 4 330 339
30. Padilla J., Kaur K., Cao H. J., Smith T. J., Phipps R. P., Peroxisome proliferator activator receptor- γ agonists and 15-deoxy- Δ 12, 14 -PG J 2 induce apoptosis in normal and malignant B-lineage cells Journal of Immunology 2000 165 12 6941 6948
31. Sato H., Ishihara S., Kawashima K., Expression of peroxisome proliferator-activated receptor (PPAR) γ in gastric cancer and inhibitory effects of PPAR γ agonists British Journal of Cancer 2000 83 10 1394 1400
32. Takashima T., Fujiwara Y., Higuchi K., PPAR-gamma ligands inhibit growth of human esophageal adenocarcinoma cells through induction of apoptosis, cell cycle arrest and reduction of ornithine decarboxylase activity International Journal of Oncology 2001 19 3 465 471
33. Yang W.-L., Frucht H., Activation of the PPAR pathway induces apoptosis and COX-2 inhibition in HT-29 human colon cancer cells Carcinogenesis 2001 22 9 1379 1383
34. Zou W., Liu X., Yue P., Khuri F. R., Sun S.-Y., PPAR γ ligands enhance TRAIL-induced apoptosis through DR5 upregulation and c-FLIP downregulation in human lung cancer cells Cancer Biology and Therapy 2007 6 1 99 106
35. Tsubouchi Y., Sano H., Kawahito Y., Inhibition of human lung cancer cell growth by the peroxisome proliferator-activated receptor- γ agonists through induction of apoptosis Biochemical and Biophysical Research Communications 2000 270 2 400 405
36. Eibl G., Wente M. N., Reber H. A., Hines O. J., Peroxisome proliferator-activated receptor γ induces pancreatic cancer cell apoptosis Biochemical and Biophysical Research Communications 2001 287 2 522 529
37. Date M., Fukuchi K., Morita S., Takahashi H., Ohura K., 15-deoxy- Δ 12, 14 -prostaglandin J 2, a ligand for peroxisome proliferators-activated receptor- γ, induces apoptosis in human hepatoma cells Liver International 2003 23 6 460 466
38. Eucker J., Bängeroth K., Zavrski I., Ligands of peroxisome proliferator-activated receptor γ induce apoptosis in multiple myeloma Anti-Cancer Drugs 2004 15 10 955 960
39. Strakova N., Ehrmann J., Bartos J., Malikova J., Dolezel J., Kolar Z., Peroxisome proliferator-activated receptors (PPAR) agonists affect cell viability, apoptosis and expression of cell cycle related proteins in cell lines of glial brain tumors Neoplasma 2005 52 2 126 136
40. Oyadomari S., Mori M., Roles of CHOP/GADD153 in endoplasmic reticulum stress Cell Death and Differentiation 2004 11 4 381 389
41. Yamaguchi K., Lee S.-H., Eling T. E., Baek S. J., A novel peroxisome proliferator-activated receptor γ ligand, MCC-555, induces apoptosis via posttranscriptional regulation of NAG-1 in colorectal cancer cells Molecular Cancer Therapeutics 2006 5 5 1352 1361
42. Weng J.-R., Chen C.-Y., Pinzone J. J., Ringel M. D., Chen C.-S., Beyond peroxisome proliferator-activated receptor γ signaling: the multi-facets of the antitumor effect of thiazolidinediones Endocrine-Related Cancer 2006 13 2 401 413
43. Diaz J.-L., Oltersdorf T., Horne W., A common binding site mediates heterodimerization and homodimerization of Bcl-2 family members Journal of Biological Chemistry 1997 272 17 11350 11355
44. Finnegan N. M., Curtin J. F., Prevost G., Morgan B., Cotter T. G., Induction of apoptosis in prostate carcinoma cells by BH3 peptides which inhibit Bak/Bcl-2 interactions British Journal of Cancer 2001 85 1 115 121
45. Göke R., Göke A., Göke B., El-Deiry W. S., Chen Y., Pioglitazone inhibits growth of carcinoid cells and promotes TRAIL-induced apoptosis by induction of p21waf1/cip1 Digestion 2001 64 2 75 80
46. Göke R., Göke A., Göke B., Chen Y., Regulation of TRAIL-induced apoptosis by transcription factors Cellular Immunology 2000 201 2 77 82
47. Nakata S., Yoshida T., Shiraishi T., 15-deoxy- Δ 12, 14 -prostaglandin J 2 induces death receptor 5 expression through mRNA stabilization independently of PPAR γ and potentiates TRAIL-induced apoptosis Molecular Cancer Therapeutics 2006 5 7 1827 1835
48. Lu M., Kwan T., Yu C., Peroxisome proliferator-activated receptor γ agonists promote TRAIL-induced apoptosis by reducing survivin levels via cyclin D3 repression and cell cycle arrest Journal of Biological Chemistry 2005 280 8 6742 6751
49. Kim Y. H., Jung E. M., Lee T.-J., Rosiglitazone promotes tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by reactive oxygen species-mediated up-regulation of death receptor 5 and down-regulation of c-FLIP Free Radical Biology and Medicine 2008 44 6 1055 1068
50. Kim Y., Suh N., Sporn M., Reed J. C., An inducible pathway for degradation of FLIP protein sensitizes tumor cells to TRAIL-induced apoptosis Journal of Biological Chemistry 2002 277 25 22320 22329
51. Schultze K., Böck B., Eckert A., Troglitazone sensitizes tumor cells to TRAIL-induced apoptosis via down-regulation of FLIP and Survivin Apoptosis 2006 11 9 1503 1512
52. Schultze K., Böck B., Eckert A., Troglitazone sensitizes tumor cells to TRAIL-induced apoptosis via down-regulation of FLIP and Survivin Apoptosis 2006 11 9 1503 1512
53. Akasaki Y., Liu G., Matundan H. H., A peroxisome proliferator-activated receptor- γ agonist, troglitazone, facilitates caspase-8 and -9 activities by increasing the enzymatic activity of protein-tyrosine phosphatase-1B on human glioma cells Journal of Biological Chemistry 2006 281 10 6165 6174
54. Avis I., Martínez A., Tauler J., Inhibitors of the arachidonic acid pathway and peroxisome proliferator-activated receptor ligands have superadditive effects on lung cancer growth inhibition Cancer Research 2005 65 10 4181 4190
55. Konopleva M., Elstner E., McQueen T. J., Peroxisome proliferator- activated receptor γ and retinoid X receptor ligands are potent inducers of differentiation and apoptosis in leukemias Molecular Cancer Therapeutics 2004 3 10 1249 1262
56. Girnun G. D., Naseri E., Vafai S. B., Synergy between PPAR γ ligands and platinum-based drugs in cancer Cancer Cell 2007 11 5 395 406
57. Liu H., Zang C., Fenner M. H., Growth inhibition and apoptosis in human Philadelphia chromosome-positive lymphoblastic leukemia cell lines by treatment with the dual PPAR α / γ ligand TZD18 Blood 2006 107 9 3683 3692
58. Zang C., Liu H., Waechter M., Dual PPAR α / γ ligand TZD18 either alone or in combination with imatinib inhibits proliferation and induces apoptosis of human CML cell lines Cell Cycle 2006 5 19 2237 2243
59. Copland J. A., Marlow L. A., Kurakata S., Novel high-affinity PPAR γ agonist alone and in combination with paclitaxel inhibits human anaplastic thyroid carcinoma tumor growth via p21WAF1/CIP1 Oncogene 2006 25 16 2304 2317
60. Fulzele S. V., Chatterjee A., Shaik M. S., Jackson T., Ichite N., Singh M., 15-deoxy- Δ 12, 14 -prostaglandin J 2 enhances docetaxel anti-tumor activity against A549 and H460 non-small-cell lung cancer cell lines and xenograft tumors Anti-Cancer Drugs 2007 18 1 65 78
61. Chung Y. W., Han D. S., Kang E. K., Effects of peroxisome proliferator-activated receptor-gamma agonist on Fas-mediated apoptosis in HT-29 cells The Korean Journal of Gastroenterology 2003 42 1 35 41
62. Mody M., Dharker N., Bloomston M., Rosiglitazone sensitizes MDA-MB-231 breast cancer cells to anti-tumour effects of tumour necrosis factor- α, CH11 and CYC202 Endocrine-Related Cancer 2007 14 2 305 315
63. Nam D.-H., Ramachandran S., Song D.-K., Growth inhibition and apoptosis induced in human leiomyoma cells by treatment with the PPAR gamma ligand ciglitizone Molecular Human Reproduction 2007 13 11 829 836
64. Avis I., Hong S. H., Martinez A., Five-lipoxygenase inhibitors can mediate apoptosis in human breast cancer cell lines through complex eicosanoid interactions The FASEB Journal 2001 15 11 2007 2009
65. Crowe D. L., Chandraratna R. A., A retinoid X receptor (RXR)-selective retinoid reveals that RXR- α is potentially a therapeutic target in breast cancer cell lines, and that it potentiates antiproliferative and apoptotic responses to peroxisome proliferator-activated receptor ligands Breast Cancer Research 2004 6 5 R546 R555
66. Giordano T. J., Au A. Y. M., Kuick R., Delineation, functional validation, and bioinformatic evaluation of gene expression in thyroid follicular carcinomas with the PAX8-PPARG translocation Clinical Cancer Research 2006 12 7 1983 1993
67. Burton J. D., Castillo M. E., Goldenberg D. M., Blumenthal R. D., Peroxisome proliferator-activated receptor- γ antagonists exhibit potent antiproliferative effects versus many hematopoietic and epithelial cancer cell lines Anti-Cancer Drugs 2007 18 5 525 534
68. Seargent J. M., Yates E. A., Gill J. H., GW9662, a potent antagonist of PPAR γ, inhibits growth of breast tumour cells and promotes the anticancer effects of the PPAR γ agonist rosiglitazone, independently of PPAR γ activation British Journal of Pharmacology 2004 143 8 933 937
69. Masuda T., Wada K., Nakajima A., Critical role of peroxisome proliferator-activated receptor γ on anoikis and invasion of squamous cell carcinoma Clinical Cancer Research 2005 11 11 4012 4021
70. Schaefer K. L., Takahashi H., Morales V. M., PPAR γ inhibitors reduce tubulin protein levels by a PPAR γ, PPAR δ and proteasome-independent mechanism, resulting in cell cycle arrest, apoptosis and reduced metastasis of colorectal carcinoma cells International Journal of Cancer 2007 120 3 702 713
71. Lefebvre A.-M., Chen I., Desreumaux P., Activation of the peroxisome proliferator-activated receptor γ promotes the development of colon tumors in C57BL/6J- APC Min/+ mice Nature Medicine 1998 4 9 1053 1057
72. Saez E., Tontonoz P., Nelson M. C., Activators of the nuclear receptor PPAR γ enhance colon polyp formation Nature Medicine 1998 4 9 1058 1061
73. Nikitakis N. G., Hebert C., Lopes M. A., Reynolds M. A., Sauk J. J., PPAR γ -mediated antineoplastic effect of NSAID sulindac on human oral squamous carcinoma cells International Journal of Cancer 2002 98 6 817 823
74. Cui Y., Lu Z., Bai L., Shi Z., Zhao W.-E., Zhao B., β -carotene induces apoptosis and up-regulates peroxisome proliferator-activated receptor γ expression and reactive oxygen species production in MCF-7 cancer cells European Journal of Cancer 2007 43 17 2590 2601
75. Ulrich S., Wächtershäuser A., Loitsch S., von Knethen A., Brüne B., Stein J., Activation of PPAR γ is not involved in butyrate-induced epithelial cell differentiation Experimental Cell Research 2005 310 1 196 204
76. Schwab M., Reynders V., Ulrich S., Zahn N., Stein J., Schröder O., PPAR γ is a key target of butyrate-induced caspase-3 activation in the colorectal cancer cell line Caco-2 Apoptosis 2006 11 10 1801 1811
77. Kim C.-S., Park W.-H., Park J.-Y., Capsaicin, a spicy component of hot pepper, induces apoptosis by activation of the peroxisome proliferator-activated receptor γ in HT-29 human colon cancer cells Journal of Medicinal Food 2004 7 3 267 273
78. Hinz B., Ramer R., Eichele K., Weinzierl U., Brune K., Up-regulation of cyclooxygenase-2 expression is involved in R (+)-methanandamide-induced apoptotic death of human neuroglioma cells Molecular Pharmacology 2004 66 6 1643 1651
79. Na H.-K., Inoue H., Surh Y.-J., ET-18-O- CH 3 -induced apoptosis is causally linked to COX-2 upregulation in H-ras transformed human breast epithelial cells FEBS Letters 2005 579 27 6279 6287
80. Eichele K., Ramer R., Hinz B., Decisive role of cyclooxygenase-2 and lipocalin-type prostaglandin D synthase in chemotherapeutics-induced apoptosis of human cervical carcinoma cells Oncogene 2008 27 21 3032 3044
81. Pon Y. L., Wong A. S. T., Gonadotropin-induced apoptosis in human ovarian surface epithelial cells is associated with cyclooxygenase-2 up-regulation via the β -catenin/T-cell factor signaling pathway Molecular Endocrinology 2006 20 12 3336 3350
82. Hasegawa H., Yamada Y., Komiyama K., A novel natural compound, a cycloanthranilylproline derivative (Fuligocandin B), sensitizes leukemia cells to apoptosis induced by tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) through 15-deoxy- Δ 12, 14 prostaglandin J 2 production Blood 2007 110 5 1664 1674